90 related articles for article (PubMed ID: 8427396)
1. Continuous infusion of cefazolin is superior to intermittent dosing in decreasing infection after hemorrhagic shock.
Livingston DH; Wang MT
Am J Surg; 1993 Feb; 165(2):203-7. PubMed ID: 8427396
[TBL] [Abstract][Full Text] [Related]
2. More is better. Antibiotic management after hemorrhagic shock.
Livingston DH; Shumate CR; Polk HC; Malangoni MA
Ann Surg; 1988 Oct; 208(4):451-9. PubMed ID: 3178333
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and pharmacokinetics of site-specific cefazolin delivery using biodegradable implants in the prevention of post-operative wound infections.
Allababidi S; Shah JC
Pharm Res; 1998 Feb; 15(2):325-33. PubMed ID: 9523322
[TBL] [Abstract][Full Text] [Related]
4. Increasing antibiotic dose decreases polymicrobial infection after hemorrhagic shock.
Livingston DH; Malangoni MA
Surg Gynecol Obstet; 1993 May; 176(5):418-22. PubMed ID: 8480263
[TBL] [Abstract][Full Text] [Related]
5. Immune enhancement by tumor necrosis factor-alpha improves antibiotic efficacy after hemorrhagic shock.
Livingston DH; Malangoni MA; Sonnenfeld G
J Trauma; 1989 Jul; 29(7):967-70; discussion 970-1. PubMed ID: 2501510
[TBL] [Abstract][Full Text] [Related]
6. Cefazolin bolus and continuous administration for elective cardiac surgery: improved pharmacokinetic and pharmacodynamic parameters.
Adembri C; Ristori R; Chelazzi C; Arrigucci S; Cassetta MI; De Gaudio AR; Novelli A
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):471-5. PubMed ID: 20570290
[TBL] [Abstract][Full Text] [Related]
7. A pilot study to determine the feasibility of continuous cefazolin infusion.
Waltrip T; Lewis R; Young V; Farmer M; Clayton S; Myers S; Gray LA; Galandiuk S
Surg Infect (Larchmt); 2002; 3(1):5-9. PubMed ID: 12593694
[TBL] [Abstract][Full Text] [Related]
8. Second place winner of the Conrad Jobst Award in the gold medal paper competition. Increased antibiotic effectiveness in a model of surgical infection through continuous infusion.
Naziri W; Cheadle WG; Trachtenberg LS; Montgomery WD; Polk HC
Am Surg; 1995 Jan; 61(1):11-5. PubMed ID: 7832374
[TBL] [Abstract][Full Text] [Related]
9. The critical relationship of antibiotic dose and bacterial contamination in experimental infection.
Citak MS; Cué JI; Peyton JC; Malangoni MA
J Surg Res; 1992 Feb; 52(2):127-30. PubMed ID: 1740934
[TBL] [Abstract][Full Text] [Related]
10. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
Atahan E; Gul M; Ergun Y; Eroglu E
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
[TBL] [Abstract][Full Text] [Related]
11. Use of cefazolin microspheres to treat localized methicillin-resistant Staphylococcus aureus infections in rats.
Fallon MT; Shafer W; Jacob E
J Surg Res; 1999 Sep; 86(1):97-102. PubMed ID: 10452874
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma restores immune competence after hemorrhagic shock.
Livingston DH; Malangoni MA
J Surg Res; 1988 Jul; 45(1):37-43. PubMed ID: 3134579
[TBL] [Abstract][Full Text] [Related]
13. An experimental study of susceptibility to infection after hemorrhagic shock.
Livingston DH; Malangoni MA
Surg Gynecol Obstet; 1989 Feb; 168(2):138-42. PubMed ID: 2911791
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological study of cefazolin during intermittent and continuous infusion: a crossover investigation in humans.
Thys JP; Vanderkelen B; Klastersky J
Antimicrob Agents Chemother; 1976 Sep; 10(3):395-8. PubMed ID: 984782
[TBL] [Abstract][Full Text] [Related]
15. Impact of Intraoperative Continuous-Infusion Versus Intermittent Dosing of Cefazolin Therapy on the Incidence of Surgical Site Infections After Coronary Artery Bypass Grafting.
Shoulders BR; Crow JR; Davis SL; Whitman GJ; Gavin M; Lester L; Barodka V; Dzintars K
Pharmacotherapy; 2016 Feb; 36(2):166-73. PubMed ID: 26799442
[TBL] [Abstract][Full Text] [Related]
16. Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations.
Zeller V; Durand F; Kitzis MD; Lhotellier L; Ziza JM; Mamoudy P; Desplaces N
Antimicrob Agents Chemother; 2009 Mar; 53(3):883-7. PubMed ID: 19075069
[TBL] [Abstract][Full Text] [Related]
17. Mild hemorrhagic shock does not enhance the risk of CD18 blockade to S. aureus skin inoculations.
Sasaki SS; Sharar SR; Harlan JM; Rice CL; Winn RK
J Appl Physiol (1985); 1994 Jan; 76(1):86-90. PubMed ID: 7909796
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin.
Mauerhan DR; Nelson CL; Smith DL; Fitzgerald RH; Slama TG; Petty RW; Jones RE; Evans RP
J Bone Joint Surg Am; 1994 Jan; 76(1):39-45. PubMed ID: 8288664
[TBL] [Abstract][Full Text] [Related]
19. [Effect of different volumes of fluid resuscitation on hemorrhagic shock with pulmonary edema at high altitude in the unacclimated rat].
Liu LM; Hu DY; Liu JC; Li P; Liu HD; Xiao N; Zhou XW; Tian KL; Huo XP; Shi QG; He YM; Yin ZM
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 May; 15(5):279-83. PubMed ID: 12837187
[TBL] [Abstract][Full Text] [Related]
20. Comparative prophylactic efficacy of cefazolin and vancomycin in a guinea pig model of Staphylococcus aureus wound infection.
Kernodle DS; Kaiser AB
J Infect Dis; 1993 Jul; 168(1):152-7. PubMed ID: 8515103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
